Skip to content

Treatment / Procedure

Supportive Care and Bioresonance in Cancer: Symptom Management and Holistic Approach

A guide explaining the supportive role of bioresonance in pain, fatigue, sleep, and quality of life goals alongside the oncology plan during cancer treatment.

Short answerA small, uncontrolled palliative study published on bioresonance in cancer reported some symptom improvements; however, it does not demonstrate tumor control or survival efficacy. Oncological treatments continue to be the primary approach.

Why is supportive care important?

During cancer treatment, pain, nausea, fatigue, sleep problems, appetite changes, anxiety, and loss of daily functioning may occur. Supportive and palliative care aim to reduce these burdens and maintain quality of life; they can be carried out concurrently with oncological treatment.

What do early clinical data say about bioresonance?

In a small, uncontrolled clinical report published in 2018, improvement in certain symptoms was reported following bioresonance administration in metastatic cancer patients. The study had no control group, its sample size was small, and the results were evaluated based on symptomatic response.

Therefore, the study does not demonstrate efficacy regarding tumor shrinkage, disease control, or survival. The findings can only be evaluated as an early observation for better-designed research on palliative goals such as pain, fatigue, sleep, and overall well-being.

Evidence-based supportive care

Depending on the symptom, pain and nausea management, nutritional support, physical rehabilitation, sleep adjustments, and psychological and social support can be planned. If complementary practices are used, goals are determined in advance and compatibility with oncological treatment is observed.

The role of bioresonance

Bioresonance should not be presented as a tumor-directed treatment. If it is to be used, it should be addressed solely for symptom management or well-being goals, without altering the oncology plan, and with claims of efficacy limited to the level of evidence.

Our approach at our Bodrum clinic

Based on the oncology team’s treatment plan, we evaluate pain, sleep, fatigue, movement capacity, nutrition, and psychosocial burden together. If bioresonance is preferred, we establish the purpose and follow-up criteria from the outset, addressing it solely as a component of supportive care.

Safety

Bioresonance is not an alternative to surgery, chemotherapy, radiotherapy, immunotherapy, or targeted therapies. New or rapidly worsening pain, fever, shortness of breath, changes in consciousness, bleeding, or inability to feed require prompt medical evaluation.

References

  1. World Health Organization. Palliative care.
  2. World Health Organization. Cancer fact sheet.
  3. Palliative Bioresonance Therapy for Metastatic Cancer Patients. Jour Radiat Oncol Palliat. 2018;1(2):31-35.

Medical editorial information

This content has been medically reviewed and approved by Dr. Kerem Çağlayan. It is intended for general education and does not replace an individual diagnosis or treatment plan.